D3 Bio

Biotech & Life Sciences · Wuxi, China · Founded 2020

Building a global biotechnology company that develops innovative and more efficacious medicines for patients in need worldwide

Valuation $1–2.5B

Headcount <100

Unlock exact values

Power Law Unicorn$1–10B valuation tier

Talent graph

D3 Bio's talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on D3 Bio's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 6 investors entered at this stage

Medicxi

Matrix Partners China

HSG

Boyu Capital

WuXi AppTec

Temasek

Series B+ 2 investors entered at this stage

IDG Capital

MPCi

Ownership

Who owns D3 Bio

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

42% Founders

WuXi AppTec 7.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where D3 Bio has talent and traffic

Workforce by country

4 countries with
team presence

🇨🇳 China75.3%

🇺🇸 United States14.8%

🇩🇪 Germany4.9%

🇹🇼 Taiwan4.9%

4 countries shown

Web traffic by country

2K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$10M patent portfolio · 14 active families

Estimated portfolio value

$10M

1.0% of valuation · 3.6× smaller than top peer Praxis Precision Medicines ($36M)

14 active patent families

Where D3 Bio innovates BiochemistryCarcinosisCombinatorial chemistryDiseasePharmaceutical Substances

Where D3 Bio concentrates vs peers

Each axis is a top-10 topic across D3 Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about D3 Bio

An AI-synthesized read of the highest-engagement posts about D3 Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See D3 Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles